Meloxicam in pain syndrome treatment of comorbid diseases patients
The issue nonsteroidal anti-inflammatory drugs (NSAIDs) use safety is associated with a high frequency of adverse events (AEs) from the gastrointestinal tract and cardiovascular risks. Patients with lower back pain (LBP) and osteoarthritis (OA), as a rule, have comorbid diseases, such as arterial hy...
Main Authors: | O. A. Shavlovskaya, I. A. Bokova, N. I. Shavlovskiy |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2021-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/6552 |
Similar Items
-
Meloxicam efficacy and safety in treatment of pain syndromes of different localization according to domestic studies
by: O. A. Shavlovskaya, et al.
Published: (2021-12-01) -
CAUSES, DIAGNOSIS AND TREATMENT OF UNSPECIFIC LUMBALGIA: MYTHS AND REALITY
by: V. A. Parfenov, et al.
Published: (2017-05-01) -
Clinical experience with meloxicam (Movalis®) in nonspecific back pain and radiculopathy
by: O N Gerasimova, et al.
Published: (2012-06-01) -
Issues of safety and pharmacoeconomics in the treatment of chronic pain in the back and limbs
by: V. A. Parfenov, et al.
Published: (2011-06-01) -
TREATMENT FOR ACUTE NONSPECIFIC BACK PAIN IN OUTPATIENT PRACTICE
by: O. N. Gerasimova, et al.
Published: (2009-12-01)